HIMS · Hims & Hers Health Inc.
AI read · Neutral
The AI's read
HIMS reported mixed Q2: a big EPS miss of $0.37 versus a -$0.03 estimate, but revenue beat at $753.21M and subscribers rose to ~2.9M. The company also raised FY26 revenue guidance to $3.1–$3.3B, yet the earnings miss triggered downside in after-hours action. Price action shows investors reacted. Shares fell about 5.6% in extended trading while on-chain indicators show HIMS is technically oversold with RSI 23.82. Bottom line: mixed fundamentals create split incentives. We lean bearish because the EPS miss and immediate selling outweigh the revenue/guidance beat, but remain cautious given oversold conditions and strong top-line trends.